Abstracts

Altering the Prime Affects ALVAC-SIV/gp120 Immunogenicity and Efficacy

Background: The 31.2% efficacy afforded by ALVAC-HIV/gp120 in the RV144 Thai Trial needs to be improved. ALVAC-SIV/gp120 vaccines tested in a SIVmac251 macaque model also demonstrated partial efficacy ~40% at each challenge. DNA vaccines and alternate adenoviral vectors such as Adenovirus 26 are clinically relevant vaccine candidates that could be used in combination with ALVAC/gp120.…

Conserved Element DNA Vaccine based on HIV-1 or SIV sequences Increases T-cell Breadth

Background: HIV sequence diversity and potential “decoy” epitopes are hurdles in the development of an effective AIDS vaccine. We tested the hypothesis that a vaccine candidate composed of highly Conserved Elements (CE) of the HIV proteome excluding the variable regions would help overcome these problems. CE were selected based on both stringent conservation and association…

DNA and Protein Co-immunization Improves the Magnitude and Longevity of Humoral Immune Responses

Background: Understanding the quality of immune responses induced by different vaccine regimens is essential for improving the prospects of AIDS vaccines. Methodology: To identify optimal regimens, we compared vaccination protocols that used DNA, protein, or a combination of DNA and protein using a classical prime/boost strategy or delivered in a co-immunization regimen combining the two…

Immunization of Humanized BLT Mice Against HIV Influences Early Immune Responses and Viral Loads

Background: The precise specificity of humoral and cellular immune responses has been shown to affect the control of SIV/HIV replication. While the SIVinfected rhesus macaque model has proven invaluable for elucidation of the mechanisms of HIV disease pathogenesis and vaccine efficacy, differences in host and viral genetics limit the model’s use for the study of…

Incidence and Predicting Factors of Pregnancy Post-ART Initiation in 9 West African Countries

Background: In sub-Saharan Africa, women of reproductive age constitute the most HIV-affected population. Since antiretroviral therapy (ART) has become widely available, HIV-infected women health status has improved and the pregnancy rate post-ART has risen. In order to correctly respond to reproductive health needs of HIV-infected women in reproductive age, estimating incidence and predicting factors of…

Pregnancy and Retention or Progression to AIDS/Death Post-ART in 9 West African Countries

Background: We hypothesized that pregnancy after antiretroviral therapy (ART) initiation may impact health outcomes among HIV-infected women. The objectives of this west-African multi-country study were to assess whether pregnancy post-ART initiation had an effect on the risk of loss to follow-up (LTFU), AIDS progression or death and on CD4 cells gain. Methodology: This retrospective cohort…

PrEP Is Efficacious for HIV Prevention Among Women Using DMPA for Contraception

Background: Pre-exposure prophylaxis (PrEP), using daily oral tenofovir disoproxil fumarate (TDF) or combination emtricitabine (FTC)/TDF, is a proven HIV prevention strategy. Observational studies have suggested that the injectable contraceptive depot medroxyprogesterone acetate (DMPA) may increase the risk for HIV acquisition among women. Whether PrEP is efficacious for HIV prevention among women using DMPA has not…

High Initiation of PrEP and ART in a Demonstration Project Among African HIV-Discordant Couples

Background: PrEP and ART have demonstrated high efficacy for HIV prevention among African HIV serodiscordant couples. Assessing delivery, uptake of and adherence to antiretroviral strategies for HIV prevention outside of clinical trial settings is a priority. Methodology: Enrollment into an open-label demonstration project of PrEP and ART among high-risk, research-naive HIV serodiscordant couples from 4…

High Medication Adherence Among HIV-1 Uninfected Women Experiencing Pregnancy in a PrEP Trial

Background: Pre-exposure prophylaxis (PrEP) may be an important safer conception strategy for HIV-1 uninfected women with an HIV-1 infected partner. Identifying pregnancy predictors and medication adherence in this population may inform whether PrEP is a feasible safer conception strategy. Methodology: We evaluated predictors of pregnancy and adherence to study medication among HIV-1 uninfected women enrolled…